Cargando…
Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter
Chronic sequelae after surviving Covid 19 disease, and also after inapparent or asymptomatic SARS-CoV‑2 infections, represent an increasingly common problem despite the growing number of vaccinated individuals and significantly reduced infection rates in the summer of 2021. For these sufferers of “p...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496622/ http://dx.doi.org/10.1007/s00052-021-00023-3 |
_version_ | 1784579791216705536 |
---|---|
author | Thede, Christian |
author_facet | Thede, Christian |
author_sort | Thede, Christian |
collection | PubMed |
description | Chronic sequelae after surviving Covid 19 disease, and also after inapparent or asymptomatic SARS-CoV‑2 infections, represent an increasingly common problem despite the growing number of vaccinated individuals and significantly reduced infection rates in the summer of 2021. For these sufferers of “post-Covid syndrome” Western medicine has been unable to date to offer any significant, established and effective therapy options. In this article, the author presents effective therapeutic concepts offered by Chinese herbal therapy for the treatment of the particularly frequent respiratory and neurological symptoms as well as for “chronic fatigue syndrome” (CFS), with special emphasis on the treatment of special forms of Covid-19 sequelae such as disharmony of lesser yang (shaoyang) with variations of “minor bupleurum decoction” (xiao chaihu tang), also with regard to possible reactivations of chronic EBV infections by corona-virus infections. The article also discusses the significance of Long Covid in children and adolescents and outlines possible therapeutic concepts. The article concludes with two case studies. |
format | Online Article Text |
id | pubmed-8496622 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-84966222021-10-08 Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter Thede, Christian Chinese Medicine Zertifizierte Fortbildung Chronic sequelae after surviving Covid 19 disease, and also after inapparent or asymptomatic SARS-CoV‑2 infections, represent an increasingly common problem despite the growing number of vaccinated individuals and significantly reduced infection rates in the summer of 2021. For these sufferers of “post-Covid syndrome” Western medicine has been unable to date to offer any significant, established and effective therapy options. In this article, the author presents effective therapeutic concepts offered by Chinese herbal therapy for the treatment of the particularly frequent respiratory and neurological symptoms as well as for “chronic fatigue syndrome” (CFS), with special emphasis on the treatment of special forms of Covid-19 sequelae such as disharmony of lesser yang (shaoyang) with variations of “minor bupleurum decoction” (xiao chaihu tang), also with regard to possible reactivations of chronic EBV infections by corona-virus infections. The article also discusses the significance of Long Covid in children and adolescents and outlines possible therapeutic concepts. The article concludes with two case studies. Springer Medizin 2021-10-07 2021 /pmc/articles/PMC8496622/ http://dx.doi.org/10.1007/s00052-021-00023-3 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Zertifizierte Fortbildung Thede, Christian Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter |
title | Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter |
title_full | Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter |
title_fullStr | Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter |
title_full_unstemmed | Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter |
title_short | Therapie von Long-Covid-Syndromen mit chinesischer Arzneimitteltherapie im Erwachsenen‑, Kindes- und Jugendalter |
title_sort | therapie von long-covid-syndromen mit chinesischer arzneimitteltherapie im erwachsenen‑, kindes- und jugendalter |
topic | Zertifizierte Fortbildung |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496622/ http://dx.doi.org/10.1007/s00052-021-00023-3 |
work_keys_str_mv | AT thedechristian therapievonlongcovidsyndromenmitchinesischerarzneimitteltherapieimerwachsenenkindesundjugendalter |